| Literature DB >> 28716576 |
Marcin Cebula1, Mathias Riehn1, Upneet Hillebrand1, Ramona F Kratzer2, Florian Kreppel2, Georgia Koutsoumpli3, Toos Daemen3, Hansjörg Hauser1, Dagmar Wirth4.
Abstract
Immune defense against hepatotropic viruses such as hepatitis B (HBV) and hepatitis C (HCV) poses a major challenge for therapeutic approaches. Intrahepatic cytotoxic CD8 T cells that are crucial for an immune response against these viruses often become exhausted resulting in chronic infection. We elucidated the T cell response upon therapeutic vaccination in inducible transgenic mouse models in which variable percentages of antigen-expressing hepatocytes can be adjusted, providing mosaic antigen distribution and reflecting the varying viral antigen loads observed in patients. Vaccination-induced endogenous CD8 T cells could eliminate low antigen loads in liver but were functionally impaired if confronted with elevated antigen loads. Strikingly, only by conditioning the liver environment with TLR9 ligand prior and early after peripheral vaccination, successful immunization against high intrahepatic antigen density with its elimination was achieved. Moreover, TLR9 immunomodulation was also indispensable for functional memory recall after high frequency antigen challenge. Together, the results indicate that TLR9-mediated conditioning of liver environment during therapeutic vaccination or antigen reoccurrence is crucial for an efficacious intrahepatic T cell response.Entities:
Keywords: CD8 T cells; HBV; HCV; antigen load; hepatic viral infection; hepatitis; immune regulation; liver; vaccination
Mesh:
Substances:
Year: 2017 PMID: 28716576 PMCID: PMC5628774 DOI: 10.1016/j.ymthe.2017.06.018
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454